β-TCP offers the ideal conditions for biologically functional bone growth. It has been used worldwide for the safe and effective treatment of bone defects.
BoneFlo®+ was designed by Roth Industries GmbH & Co. KG and TissueFlow. Besides the EU and the state of NRW, TissueFlow is supported by the University Hospital Essen, Germany.
